Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Arteriosclerosis, Thrombosis, and Vascular Biology. 1993;13:1602-1612

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swords, N. A.
Right arrow Articles by Mann, K. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swords, N. A.
Right arrow Articles by Mann, K. G.

Arteriosclerosis and Thrombosis, Vol 13, 1602-1612, Copyright © 1993 by American Heart Association

ARTICLES

The assembly of the prothrombinase complex on adherent platelets

NA Swords and KG Mann
Department of Biochemistry, College of Medicine, University of Vermont, Burlington 05405.

Prothrombinase complex assembly, in real time, on platelets adherent to immobilized von Willebrand Factor (vWf) was examined by total internal reflection fluorescence spectroscopy (TIRFS). Electron microscopy showed that the platelets adhered to vWf in a largely unactivated state and could be activated by thrombin. Antibody binding to glycoprotein (GP) Ib and functional GPIIb-IIIa receptor molecules on adherent platelet membranes monitored by TIRFS also indicated that platelets adhered in a largely unactivated state. Maximal expression of the receptor form of GPIIb-IIIa detected by antibody binding was seen only after thrombin stimulation of the adherent platelets. Antibody binding to GPIb was detected on adherent platelets. A reduction in antibody binding was observed after thrombin stimulation of the platelets, indicating a change in GPIb as a consequence of thrombin stimulation of the platelets. The binding of the protein components of the prothrombinase complex to adherent and thrombin-stimulated adherent platelets was then studied individually. Factor Va bound to adherent and thrombin-stimulated adherent platelets was then studied individually. Factor Va bound to adherent and thrombin-stimulated adherent platelets with an estimated Kd of 58 nmol/L. Minimal factor Xa binding was observed on adherent platelets before thrombin stimulation. Factor Xa binding was, however, readily observed on thrombin-stimulated adherent platelets. This factor Xa binding was not saturable, and no Kd value could be estimated. Direct measurement of prothrombinase complex assembly was demonstrated by using an energy transfer phenomenon between fluorescein-labeled factor Va and rhodamine-labeled factor Xa. Prothrombinase complex assembly was observed on both adherent and thrombin-stimulated adherent platelets. The estimated Kd for the factor Va/factor Xa interaction was 4 nmol/L. TIRFS demonstrated that adherent platelets have the ability to support prothrombinase complex assembly, as shown by a direct energy transfer reaction between fluorescently labeled factors Va and Xa.


This article has been cited by other articles:


Home page
 CirculationHome page
D. J. Schneider, P. B. Tracy, K. G. Mann, and B. E. Sobel
Differential Effects of Anticoagulants on the Activation of Platelets Ex Vivo
Circulation, November 4, 1997; 96(9): 2877 - 2883.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Byrne, N. Moran, M. Maher, N. Walsh, P. Crean, and D. J. Fitzgerald
Continued Thromboxane A2 Formation Despite Administration of a Platelet Glycoprotein IIb/IIIa Antagonist in Patients Undergoing Coronary Angioplasty
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3224 - 3229.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Szczeklik, J. Musial, A. Undas, J. Swadzba, P. F. Gora, W. Piwowarska, and M. Duplaga
Inhibition of Thrombin Generation by Aspirin Is Blunted in Hypercholesterolemia
Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 948 - 954.
[Abstract] [Full Text]

Home page
 CirculationHome page
J. E. Tcheng, R. A. Harrington, K. Kottke-Marchant, N. S. Kleiman, S. G. Ellis, D. J. Kereiakes, M. J. Mick, F. I. Navetta, J. E. Smith, S. J. Worley, et al.
Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Platelet Integrin Glycoprotein IIb/IIIa Blocker Integrelin in Elective Coronary Intervention
Circulation, April 15, 1995; 91(8): 2151 - 2157.
[Abstract] [Full Text]

Home page
 PERSPECT VASC SURG ENDOVASC THERHome page
A. T. Gentile, T. G. DeLoughery, and J. M. Porter
Novel Antithrombotic Agents in Vascular Surgery
Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1994; 7(2): 57 - 72.
[PDF]

Home page
 J. Biol. Chem.Home page
J. J. Briede, G. Tans, G. M. Willems, H. C. Hemker, and T. Lindhout
Regulation of Platelet Factor Va-dependent Thrombin Generation by Activated Protein C at the Surface of Collagen-adherent Platelets
J. Biol. Chem., March 2, 2001; 276(10): 7164 - 7168.
[Abstract] [Full Text] [PDF]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.